Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion

Lin Yang,Jianjun Quan,Jian Dong,Ningning Ding,Yang Han,Longlong Cong,Yuhao Lin,Jianlin Liu

DOI: https://doi.org/10.1038/s41598-023-50511-8

IF: 4.6

2024-01-02

Scientific Reports

Abstract:Abstract This study evaluated the outcomes of a bare metal stent (BMS), DCB alone, atherectomy plus a drug-coated balloon (AT + DCB) and AT alone for the treatment of femoropopliteal artery occlusion. Four groups were included in this retrospective cohort study: 119 patients underwent the BMS procedure, 89 patients underwent DCB alone, 52 patients underwent AT + DCB, and 61 patients underwent AT alone. Patients were followed-up at 1, 6, 12 and 24 months after the procedure, the clinical outcomes and complications were assessed, and the primary outcomes were primary patency and restenosis. AT + DCB showed a lower bailout stent, and BMS displayed a higher retrograde puncture, flow-limiting dissection and postdilation ( p < 0.05). For all procedures, the walking distance, ABI and pain score post-procedure were significantly improved compared with the pre-procedure values ( p < 0.001). The restenosis rate was higher in BMS (21.0%) and AT alone (24.6%) than in DCB (10.1%) alone and AT + DCB (11.5%) ( p = 0.04); there was no difference in amputation or clinically driven target lesion revascularization among procedures. The primary patency rates were 77.7%, 89.4%, 88.0% and 73.7% in the BMS, DCB alone, AT + DCB and AT alone groups at 24 months, respectively ( p = 0.03), while the secondary patency and main adverse events (stroke, MI and death) were similar. Proximal concavity, proximal target vessel diameter ≥ 5 mm, runoff number ≥ 2 and DCB use were protective factors for primary patency. Our results suggested that AT + DCB and DCB alone were associated with higher primary patency, and DCB devices (combined with/without AT) should be the preferred choice for FP lesions.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the medium - term effects of different treatment methods in the treatment of femoropopliteal arterial occlusion (FP), especially to compare the effects of four methods: Bare Metal Stent (BMS), Drug - Coated Balloon (DCB) used alone, Atherectomy (AT) plus Drug - Coated Balloon (AT + DCB), and Atherectomy used alone (AT alone). ### Research Background Femoropopliteal arterial occlusion is one of the most common types of lower - extremity arterial occlusions. Approximately 10 - 15% of patients with intermittent claudication will develop limb - threatening ischemia within 5 years, leading to a higher risk of amputation and death. With the progress of interventional techniques and equipment, endovascular surgery has gradually become the preferred method for treating FP lesions. BMS and DCB are the two most commonly used methods, which can improve limb salvage rate and target - lesion patency rate. However, due to the existence of complex lesions such as long - segment occlusions, the restenosis rates of BMS and DCB are still relatively high, and BMS may affect subsequent treatments. ### Research Objectives This study aims to evaluate the clinical effects and complications of BMS, DCB used alone, AT + DCB, and AT used alone in the treatment of FP occlusion through a retrospective cohort study, with special attention to the primary patency rate and restenosis rate. ### Main Findings 1. **Primary Patency Rate**: - The primary patency rates at 24 months were: 77.7% in the BMS group, 89.4% in the DCB - alone group, 88.0% in the AT + DCB group, and 73.7% in the AT - alone group. - The primary patency rates in the DCB - alone group and the AT + DCB group were significantly higher than those in the BMS group and the AT - alone group (p = 0.03). 2. **Restenosis Rate**: - The restenosis rates were: 21.0% in the BMS group, 10.1% in the DCB - alone group, 11.5% in the AT + DCB group, and 24.6% in the AT - alone group. - The restenosis rates in the BMS group and the AT - alone group were significantly higher than those in the DCB - alone group and the AT + DCB group (p = 0.04). 3. **Other Clinical Indicators**: - All treatment methods had significant improvements in postoperative walking distance, ankle - brachial index (ABI), and pain score (p < 0.001). - There were no significant differences among the four methods in terms of complications, amputation rate, and major adverse events. ### Conclusion The research results show that AT + DCB and DCB used alone are associated with higher primary patency rates, while BMS and AT used alone have higher restenosis rates. Therefore, for FP lesions, it is recommended to give priority to DCB (used alone or in combination with AT). These data further support the advantages of DCB in the treatment of FP occlusion, especially when dealing with long - segment occlusions and severely calcified lesions.

Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion

The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty

Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease

Comparison Of Rotational Atherectomy And Modified Balloons Prior To Drug-Eluting Stent Implantation For The Treatment Of Heavily Calcified Coronary Lesions

Comparing plain old balloon and drug-coated balloon supported bare metal stents in the treatment of femoral-popliteal TASC D lesions

Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study

Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study

The efficacy of atherectomy combined with percutaneous transluminal angioplasty (PTA)/drug-coated balloon (DCB) compared with PTA/DCB for infrapopliteal arterial diseases: A systematic review and meta-analysis

Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial

Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty

One-year Outcomes of Drug-Eluting Stent Versus Drug-Coated Balloon for Femoropopliteal Artery Lesions: BEASTARS Study Results

The Efficacy of Drug-Coated Balloons and Drug-Eluting Stents in Infrapopliteal Revascularization: A Meta-analysis

A Retrospective Comparative Study of Twelve-Month Clinical Outcomes for Drug-Coating Balloon Angioplasty and Stent Implantation in Treating Patients with Popliteal Obstructive Lesions

Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT)

Midterm Results of Drug-Coated Balloon Alone or Combined with Rotarex Thrombectomy Device for Treatment of Subacute Femoropopliteal Artery Thrombotic Occlusion

A Retrospective Comparative Study of Mid‐Term Outcomes of Atherectomy, Drug‐Coating Balloon Angioplasty, and Plain Old Balloon Angioplasty for Isolated Atherosclerotic Popliteal Artery Lesions

Five-Year Safety and Effectiveness of Paclitaxel Drug-Coated Balloons Alone or With Provisional Bare Metal Stenting for Real-World Femoropopliteal Lesions: IN.PACT Global Study Subgroup Analysis

Drug-coated Balloon Angioplasty Versus Drug-eluting Stenting for Femoropopliteal Arterial Disease: A Review of the Current Status

[Mid- and long-term outcomes and prognostic factors of drug-coated balloon angioplasty for treatment of femoropopliteal long lesions]

Drug‐coated Balloon for the Treatment of Small Vessel Disease: 9 Months of Angiographic Results and 12 Months of Clinical Outcomes of the PEPCAD China SVD Study

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches